Market revenue in 2020 | USD 16.3 billion |
Market revenue in 2028 | USD 53.8 billion |
Growth rate | 16.1% (CAGR from 2020 to 2028) |
Largest segment | Detection kits |
Fastest growing segment | Detection Kits |
Historical data | 2018 - 2019 |
Base year | 2020 |
Forecast period | 2021 - 2028 |
Quantitative units | Revenue in USD billion |
Market segmentation | Purification Kits, Amplification Kits, Detection Kits, Isolation Kits |
Key market players worldwide | Thermo Fisher Scientific Inc, Qiagen NV, New England Biolabs, Illumina Inc, Agilent Technologies Inc, Bio-Rad Laboratories Inc, Merck KGaA, Promega, Takara Bio Inc, LGC Group, Toyobo Co Ltd |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biotechnology reagents & kits market will help companies and investors design strategic landscapes.
Detection kits was the largest segment with a revenue share of 22.7% in 2020. Horizon Databook has segmented the Germany biotechnology reagents & kits market based on purification kits, amplification kits, detection kits, isolation kits covering the revenue growth of each sub-segment from 2018 to 2028.
Several biotechnology companies in Germany are world leaders in their fields. The nation’s policy of promotion and consistency of health care is the factor that encourages R&D activities.
In Germany, there are around 580 biotechnology companies that consistently work toward innovation and development of new products. Germany spends a third the total biotechnology revenue on R&D. It accounted for around 31% of all R&D spending in the European Union. Out of 10, 6 most innovative companies in the European Union are from Germany.
For instance, in April 2021, QIAGEN introduced artus SARS-CoV-2 prep& Amp as a CE-Marked COVID-19 test that uses a liquid-based specimen preparation technology to simplify and enhance SARS-CoV-2 testing.
Horizon Databook provides a detailed overview of country-level data and insights on the Germany biotechnology reagents & kits market , including forecasts for subscribers. This country databook contains high-level insights into Germany biotechnology reagents & kits market from 2018 to 2028, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account